US Stock MarketDetailed Quotes

ENOV Enovis Corp

Watchlist
  • 37.050
  • +1.240+3.46%
Close Mar 14 16:00 ET
  • 37.050
  • 0.0000.00%
Post 16:05 ET
2.11BMarket Cap-2.48P/E (TTM)

About Enovis Corp Company

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Company Profile

SymbolENOV
Company NameEnovis Corp
Listing DateMay 8, 2008
Founded1995
CEOMr. Matthew L. Trerotola
MarketNYSE
Employees7367
Fiscal Year Ends12-31
Address2711 Centerville Road,Suite 400
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19808
Phone1-302-252-9160

Company Executives

  • Name
  • Position
  • Salary
  • Matthew L. Trerotola
  • Chairman of the Board and Chief Executive Officer
  • 10.77M
  • Bradley J. Tandy
  • Senior Vice President and Chief Legal Officer
  • --
  • John Kleckner
  • Vice President, Controller and Chief Accounting Officer
  • --
  • Brady R. Shirley
  • President, Chief Operating Officer and Director
  • 5.20M
  • Patricia A. Lang
  • Senior Vice President and Chief Human Resources Officer
  • 2.07M
  • Phillip Benjamin Berry
  • Senior Vice President and Chief Financial Officer
  • 2.36M
  • Daniel A. Pryor
  • Executive Vice President, Strategy and Business Development
  • 4.75M
  • Terry D. Ross
  • Group President, Prevention and Recovery
  • --
  • Louie Vogt
  • Group President, Reconstructive
  • --
  • Sharon L. Wienbar
  • Lead Independent Director
  • 316.46K
  • Liam J. Kelly
  • Independent Director
  • 283.93K
  • Rajiv Vinnakota
  • Independent Director
  • 298.93K
  • Philip A. Okala
  • Independent Director
  • 283.93K
  • Barbara W. Bodem
  • Independent Director
  • 283.93K
  • Angela S. Lalor
  • Independent Director
  • 296.46K
  • A. Clayton Perfall
  • Independent Director
  • 308.93K
  • Dr. Christine Ortiz, B.S.,M.S.,PhD
  • Independent Director
  • 283.93K

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More